Multi-effective characteristics and advantages of acupuncture in COVID-19 treatment

Abstract

Coronavirus disease 2019 (COVID-19) is a major disease that threatens human life and health. Its pathogenesis is complex and still not fully clarified. The clinical treatment is mainly supportive and lacks specific treatment methods. Acupuncture treatment can inhibit immune inflammatory reactions, neuroinflammatory reactions, oxidative stress levels, and hypothalamus-pituitary-adrenal (HPA) axis activity, improve lung function, and relieve migraine, fatigue, anxiety, and depression. However, whether acupuncture treatment is suitable for treating these symptoms in patients with COVID-19 still needs to be investigated. For this review, the literature was systematically searched for multiple databases to summarize the mechanisms of acupuncture treatment for COVID-19-related symptoms and complications. A complex network analysis of acupoints and symptoms was also performed to clarify acupoint selection in the acupuncture treatment of symptoms related to COVID-19. The evidence indicates that acupuncture can improve the respiratory, digestive, nervous, and mental and psychological symptoms related to COVID-19 by inhibiting immune inflammatory reactions, regulating intestinal flora, mitochondrial function, oxidative stress level, cardiomyocyte apoptosis, neurotransmitter release, and HPA axis activity, and alleviating basic diseases such as diseases of the vascular system. Acupuncture can improve various clinical and concomitant symptoms of COVID-19; however, its mechanism of action is complex and requires further study.

Keywords

Acupuncture / COVID-19 / Inflammatory factor storm / Multi-efficiency

References

[[1]] Chen N, Zhou M, Dong X, et al.Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020;395(10223):507-513.

[[2]] WHO. Coronavirus disease (COVID -19) weekly epidemio-logical update on COVID-19. 2022. Available from: https://www.who.int/emergencies/disesaes/novel-coronavirus-2019/situation-reports/. Accessed December 18, 2022.

[[3]] Huang C, Wang Y, Li X, et al.Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395(10223):497-506.

[[4]] Chen R, Lan Z, Ye J, et al.Cytokine storm: the primary determinant for the pathophysiological evolution of COVID-19 deterioration. Front Immunol 2021;12:589095.

[[5]] National Institutes of Health. Coronavirus disease 2019 (COVID- 19) treatment guidelines. Available from: https://www.covid-19 treatment guide-lines.nih.gov. Accessed January 26, 2023.

[[6]] National Health Commission.National health commission diagnosis and treatment plan for novel coronavirus pneumonia (trial version10). Available from: http://www.gov.cn/zhengce/zhengceku/2023-01/06content_5735343.htm. Accessed January 6, 2023.

[[7]] Ferner RE, Aronson JK.Chloroquine and hydroxychloroquine in COVID-19. BMJ 2020;369:m1432.

[[8]] Al-aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature 2021;594(7862):259-264.

[[9]] Spinner CD, Gottlieb RL, Criner GJ, et al; GS-US-540-5774 Investigators. Effect of Remdesivir vs standard care on clinical status at 11 days in patients with moderate COVID-19: a randomized clinical trial. JAMA 2020;324(11):1048-1057.

[[10]] World Health Organization. Coronavirus disease (COVID-19): post COVID-19 condition. Available from: https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-post-covid-19-covid-19-condition. Accessed December 16, 2021.

[[11]] Proal AD, Vanelzakker MB.Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front Microbiol 2021;12:698169.

[[12]] Phetsouphanh C, Darley DR, Wilson DB, et al.Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol 2022;23(2):210-216.

[[13]] Liu Q, Mak J, Su Q, et al.Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut 2022;71(3):544-552.

[[14]] Haffke M, Freltag H, Rudolf G, et al.Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS). J Transl Med 2022;20(1):138.

[[15]] Shan W, Hillman T, Playford ED, et al.Managing the long term effects of covid-19:summary of NICE, SIGN, and RCGP rapid guideline. BMJ 2021;372:n136.

[[16]] Davis HE, Mccorkell L, Vogel JM, et al.Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol 2023;21(3):133-146.

[[17]] Yong SJ.Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond) 2021;53(10):737-754.

[[18]] Von TP, Oei SL, Ramsenthaler C. Acupuncture for breathlessness in advanced diseases:a systematic review and meta-analysis. J Pain Symptom Manage 2020;59(2):327-338.e3.

[[19]] Xu S, Yu L, Luo X, et al.Manual acupuncture versus sham acupuncture and usual care for prophylaxis of episodic migraine without aura: multicentre, randomised clinical trial. BMJ 2020;368:m697.

[[20]] Li YY, Yin CY, Li XJ, et al.Electroacupuncture alleviates paclitaxel- induced peripheral neuropathic pain in rats via suppressing TLR4 signaling and TRPV1 upregulation in sensory neurons. Int J Mol Sci 2019;20(23):5917.

[[21]] Feng D, Zhou H, Jin X, et al.Electroacupuncture pretreatment alleviates LPS-induced acute respiratory distress syndrome via regulating the PPAR Gamma/NF-Kappa B signaling pathway. Evid Based Complement Alternat Med 2020;2020:4594631.

[[22]] Zhao X, Liu L, Wang Y, et al.Electroacupuncture enhances antioxidative signal pathway and attenuates neuropathic pain induced by chemotherapeutic paclitaxel. Physiol Res 2019;68(3):501-510.

[[23]] Zhou F, Jiang H, Kong N, et al.Electroacupuncture attenuated anxiety and depression-like behavior via inhibition of hippocampal inflammatory response and metabolic disorders in TNBSinduced IBD rats. Oxid Med Cell Longev 2022;2022:8295580.

[[24]] Lai CC, Ko WC, Lee PI, et al.Extra-respiratory manifestations of COVID-19. Int J Antimicrob Agents 2020;56(2):106024.

[[25]] Rendeiro AF, Ravichandran H, Bram Y, et al.The spatial landscape of lung pathology during COVID-19 progression. Nature 2021;593(7860):564-569.

[[26]] Zhu J, Ji P, Pang J, et al.Clinical characteristics of 3062 COVID-19 patients: a meta-analysis. J Med Virol 2020;92(10):1902-1914.

[[27]] Grant MC, Geoghegan L, Arbyn M, et al.The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARSCoV- 2; COVID-19): a systematic review and meta-analysis of 148 studies from 9 countries. PLoS One 2020;15(6):e0234765.

[[28]] Koh J, Shah SU, Chua P, et al.Epidemiological and clinical characteristics of cases during the early phase of COVID-19 pandemic: a systematic review and meta-analysis. Front Med (Lausanne) 2020;7:295.

[[29]] Rodriguez AJ, Cardona JA, Gutierrez E, et al.Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis. Travel Med Infect Dis 2020;34:101623.

[[30]] Li LQ, Huang T, Wang YQ, et al.COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis. J Med Virol 2020;92(6):577-583.

[[31]] Sun P, Qie S, Liu Z, et al.Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: a single arm meta-analysis. J Med Virol 2020;92(6):612-617.

[[32]] Cao Y, Liu X, Xiong L, et al.Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis. J Med Virol 2020;92(9):1449-1459.

[[33]] Fu L, Wang B, Yuan T, et al.Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: a systematic review and meta-analysis. J Infect 2020;80(6):656-665.

[[34]] Park JH, Jang W, Kim SW, et al.The clinical manifestations and chest computed tomography findings of coronavirus disease 2019 (COVID-19) patients in China: a proportion meta-analysis. Clin Exp Otorhinolaryngol 2020;13(2):95-105.

[[35]] Yang J, Zheng Y, Gou X, et al.Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis 2020;94:91-95.

[[36]] Seidman MD, Gurgel RK, Lin SY, et al.Clinical practice guideline: allergic rhinitis executive summary. Otolaryngol Head Neck Surg 2015;152(2):197-206.

[[37]] Mccullough AR, Pollack AJ, Plejdrup HM, et al.Antibiotics for acute respiratory infections in general practice: comparison of prescribing rates with guideline recommendations. Med J Aust 2017;207(2):65-69.

[[38]] Elnaggar RK, Moawd SA, Ali SE, et al.Potential impacts of Acu- TENS in the treatment of adolescents with moderate to severe bronchial asthma: a randomized clinical study. Complement Ther Med 2021;57:102673.

[[39]] Wang J, Li J, Yu X, et al.Acupuncture therapy for functional effects and quality of life in COPD patients: a systematic review and meta-analysis. Biomed Res Int 2018;2018:3026726.

[[40]] Xiong J, Qi W, Yang H, et al.Acupuncture treatment for cough-variant asthma: a meta-analysis. Evid Based Complement Alternat Med 2021;2021:6694936.

[[41]] Wang H, Ying H, Wang S, et al.Imbalance of peripheral blood Th17 and Treg responses in patients with chronic obstructive pulmonary disease. Clin Respir J 2015;9(3):330-341.

[[42]] Yang CH, Tian JJ, Ko WS, et al.Oligo-fucoidan improved unbalance the Th1/Th2 and Treg/Th17 ratios in asthmatic patients: an ex vivo study. Exp Ther Med 2019;17(1):3-10.

[[43]] Liang P, Peng S, Zhang M, et al. Huai Qi Huang corrects the balance of Th1/Th2 and Treg/Th17 in an ovalbumin-induced asthma mouse model. Biosci Rep 2017;37(6):BSR20171071.

[[44]] Sun J, Liu T, Yan Y, et al.The role of Th1/Th2 cytokines played in regulation of specific CD4 (+) Th1 cell conversion and activation during inflammatory reaction of chronic obstructive pulmonary disease. Scand J Immunol 2018;88(1):e12674.

[[45]] Zhao H, Dong F, Li Y, et al.Inhibiting ATG5 mediated autophagy to regulate endoplasmic reticulum stress and CD4(+) T lymphocyte differentiation: mechanisms of acupuncture's effects on asthma. Biomed Pharmacother 2021;142:112045.

[[46]] Li D, Sun T, Chi L, et al.Acupoint catgut embedding improves the lipopolysaccharide-induced acute respiratory distress syndrome in rats. Biomed Res Int 2020;2020:2394734.

[[47]] Zhang XF, Xiang SY, Geng WY, et al.Electro-acupuncture regulates the cholinergic anti-inflammatory pathway in a rat model of chronic obstructive pulmonary disease. J Integr Med 2018;16(6):418-426.

[[48]] Hua JS, Li HJ, Chen F, et al.Effect of acupuncture preconditioning combined with PI3K blocker LY294002 on airway inflammation in asthmatic rats. Zhen Ci Yan Jiu 2022;47(9):778-784.

[[49]] Geng WY, Liu ZB, Song NN, et al.Effects of electroacupuncture at Zusanli (ST36) on inflammatory cytokines in a rat model of smoke-induced chronic obstructive pulmonary disease. J Integr Med 2013;11(3):213-219.

[[50]] Wang D, Hu B, Hu C, et al.Clinical characteristics of 138 hospitalized patients with 2019 novel Coronavirus-infected pneumonia in Wuhan, China. JAMA 2020;323(11):1061-1069.

[[51]] Rokkas T.Gastrointestinal involvement in COVID-19: a systematic review and meta-analysis. Ann Gastroenterol 2020;33(4):355-365.

[[52]] Mao R, Qiu Y, He JS, et al.Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2020;5(7):667-678.

[[53]] Cheung KS, Hung I, Chan P, et al.Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong cohort: systematic review and meta-analysis. Gastroenterology 2020;159(1):81-95.

[[54]] Suresh VC, Mukherjee S, Harne PS, et al.Novelty in the gut: a systematic review and meta-analysis of the gastrointestinal manifestations of COVID-19. BMJ Open Gastroenterol 2020;7(1):e000417.

[[55]] Lyman GH, Greenlee H, Bohlke K, et al.Integrative therapies during and after breast cancer treatment: ASCO endorsement of the SIO clinical practice guideline. J Clin Oncol 2018;36(25):2647-2655.

[[56]] Shen J, Wenger N, Glaspy J, et al.Electroacupuncture for control of myeloablative chemotherapy-induced emesis: a randomized controlled trial. JAMA 2000;284(21):2755-2761.

[[57]] Qi LY, Yang JW, Yan SY, et al.Acupuncture for the treatment of diarrhea-predominant irritable bowel syndrome: a pilot randomized clinical trial. JAMA Netw Open 2022;5(12):e2248817.

[[58]] Lee B, Ko MM, Lee SH, et al.Acupuncture for the treatment of childhood anorexia: a systematic review and meta-analysis. Complement Ther Med 2022;71:102893.

[[59]] Chen J, Tu Q, Miao S, et al.Transcutaneous electrical acupoint stimulation for preventing postoperative nausea and vomiting after general anesthesia: a meta-analysis of randomized controlled trials. Int J Surg 2020;73:57-64.

[[60]] Ren X, Zhu Y, Gamallat Y, et al.E. coli O124 K72 alters the intestinal barrier and the tight junctions proteins of guinea pig intestine. Biomed Pharmacother 2017;94:468-473.

[[61]] Vindigni SM, Zisman TL, Suskind DL, et al.The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions. Therap Adv Gastroenterol 2016;9(4):606-625.

[[62]] Hou TS, Han XX, Yang Y, et al.Effect of electroacupuncture intervention on enteric microecology in ulcerative colitis rats. Zhen Ci Yan Jiu 2014;39(1):27-34.

[[63]] Wang L, An J, Song S, et al.Electroacupuncture preserves intestinal barrier integrity through modulating the gut microbiota in DSS-induced chronic colitis. Life Sci 2020;261:118473.

[[64]] Han YL, Peng XM, Zhang HX, et al.Electroacupuncture regulates TRPV1 through PAR2/PKC pathway to alleviate visceral hypersensitivity in FD rats. Evid Based Complement Alternat Med 2021;2021:1975228.

[[65]] Yang J, Shang B, Shi H, et al.The role of toll-like receptor 4 and mast cell in the ameliorating effect of electroacupuncture on visceral hypersensitivity in rats. Neurogastroenterol Motil 2019;31(6):e13583.

[[66]] Song E, Zhang C, Israelow B, et al.Neuroinvasion of SARS-CoV-2 in human and mouse brain. J Exp Med 2021;218(3):e20202135.

[[67]] Li YC, Bai WZ, Hashikawa T.The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID- 19 patients. J Med Virol 2020;92(6):552-555.

[[68]] Chiu CW, Lee TC, Hsu PC, et al.Efficacy and safety of acupuncture for dizziness and vertigo in emergency department: a pilot cohort study. BMC Complement Altern Med 2015;15:173.

[[69]] Greenlee H, Dupont MJ, Balneaves LG, et al.Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment. CA Cancer J Clin 2017;67(3):194-232.

[[70]] Wang T, Xu C, Pan K, et al.Acupuncture and moxibustion for chronic fatigue syndrome in traditional Chinese medicine: a systematic review and meta-analysis. BMC Complement Altern Med 2017;17(1):163.

[[71]] Li X, Dai Q, Shi Z, et al.Clinical efficacy and safety of electroacupuncture in migraine treatment: a systematic review and network meta-analysis. Am J Chin Med 2019;47(8):1755-1780.

[[72]] Swartjes M, Moraariu A, Niesters M, et al.Nonselective and NR2B-selective N-methyl-D-aspartic acid receptor antagonists produce antinociception and long-term relief of allodynia in acute and neuropathic pain. Anesthesiology 2011;115(1):165-174.

[[73]] Huang CP, Lin YW, Lee DY, et al.Electroacupuncture relieves CCI-induced neuropathic pain involving excitatory and inhibitory neurotransmitters. Evid Based Complement Alternat Med 2019;2019:6784735.

[[74]] Qiao LN, Liu JL, Tan LH, et al.Effect of electroacupuncture on thermal pain threshold and expression of calcitonin-gene related peptide, substance P and y-aminobutyric acid in the cervical dorsal root ganglion of rats with incisional neck pain. Acupunct Med 2017;35(4):276-283.

[[75]] Brkic S, Tomic S, Maric D, et al. Lipid peroxidation is elevated in female patients with chronic fatigue syndrome. Med Sci Monit, 2010;16(12):CR628-632.

[[76]] Zhu Y, Wang J, Yao L, et al.Electroacupuncture at BL15 attenuates chronic fatigue syndrome by downregulating iNOS/NO signaling in C57BL/6 mice. Anat Rec (Hoboken) 2022; published online May 24. Electroacupuncture at BL15 attenuates chronic fatigue syndrome by downregulating iNOS/NO signaling in C57BL/6 mice. Anat Rec (Hoboken) 2022; published online May 24. http://doi:10.1002/ar.24953.

[[77]] Wasserman D, Iosue M, Wuestefeld A, et al.Adaptation of evidence- based suicide prevention strategies during and after the COVID-19 pandemic. World Psychiatry 2020;19(3):294-306.

[[78]] Tan YQ, Wang Z, Yap QV, et al.Psychological health of surgeons in a time of COVID-19: a global survey. Ann Surg 2021;277(1):50-56.

[[79]] Qaseem A, Barry MJ, Kansagara D; Clinical Guidelines Committee of the American College of Physicians. Nonpharmacologic versus pharmacologic treatment of adult patient with major depressive disorder: a clinical practice guideline from the American college of physicians. Ann Intern Med 2016;164(5):350-359.

[[80]] Yin X, Li W, Liang T, et al.Effect of electroacupuncture on insomnia in patients with depression: a randomized clinical trial. JAMA Netw Open 2022;5(7):e2220563.

[[81]] Li M, Niu J, Yan P, et al.The effectiveness and safety of acupuncture for depression: an overview of meta-analyses. Complement Ther Med 2020;50:102202.

[[82]] Zhi CH, Ching LW, Hui JL, et al.A network meta-analysis on the effectiveness and safety of acupuncture in treating patients with major depressive disorder. Sci Rep 2021;11(1):10384.

[[83]] Maes M, Carvalho AF.The compensatory immune-regulatory reflex system (CIRS) in depression and bipolar disorder. Mol Neurobiol 2018;55(12):8885-8903.

[[84]] Kandola A, Ashdown G, Hendrikse J, et al.Physical activity and depression: towards understanding the antidepressant mechanisms of physical activity. Neurosci Biobehav Rev 2019;107:525-539.

[[85]] Le JJ, Yi T, Qi L, et al.Electroacupuncture regulate hypothalamic- pituitary-adrenal axis and enhance hippocampal serotonin system in a rat model of depression. Neurosci Lett 2016;615:66-71.

[[86]] Chen Y, Hao C, Chen W, et al.Anti-depressant effects of acupuncture: the insights from NLRP3 mediated pyroptosis and inflammation. Neurosci Lett 2022;785:136787.

[[87]] Vgontzas AN, Bixler EO, Lin HM, et al.Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary- adrenal axis: clinical implications. J Clin Endocrinol Metab 2001;86(8):3787-3794.

[[88]] Zhou Y, Chi J, Lv W, et al.Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19). Diabetes Metab Res Rev 2021;37(2):e3377.

[[89]] Cummings MJ, Baldwin MR, Abrams D, et al.Epidemiology, clinical course, and outcomes of critically ill adults with COVID- 19 in New York City: a prospective cohort study. Lancet 2020;395(10239):1763-1770.

[[90]] Li Y, Barajas H, Li B, et al.Comparative effectiveness of acupuncture and antiarrhythmic drugs for the prevention of cardiac arrhythmias: a systematic review and meta-analysis of randomized controlled trials. Front Physiol 2017;8:358.

[[91]] Yang J, Chen J, Yang M, et al.Acupuncture for hypertension. Cochrane Database Syst Rev 2018;11(11):CD008821.

[[92]] Zhao L, Li D, Zheng H, et al.Acupuncture as adjunctive therapy for chronic stable angina: a randomized clinical trial. JAMA Intern Med 2019;179(10):1388-1397.

[[93]] Liu Y, Meng HY, Khurwolah MR, et al.Acupuncture therapy for the treatment of stable angina pectoris: an updated meta-analysis of randomized controlled trials. Complement Ther Clin Pract 2019;34:247-253.

[[94]] Diabetes Branch of Chinese Medical Association. Chinese guidelines for the prevention and treatment of type 2 diabetes (2020 Edition) . Chin J Endocrine Metab 2021;37(4):311-398.

[[95]] Zhang T, Yang WX, Wang YL, et al.Electroacupuncture preconditioning attenuates acute myocardial is chemia injury through inhibiting NLRP3 inflammasome activation in mice. Life Sci 2020;248:117451.

[[96]] Wang C, Liang X, Yu Y, et al.Electroacupuncture pretreatment alleviates myocardial injury through regulating mitochondrial function. Eur J Med Res 2020;25(1):29.

[[97]] Li P, Tjen SC.Mechanism of the inhibitory effect of electroacupuncture on experimental arrhythmias. J Acupunct Meridian Stud 2013;6(2):69-81.

[[98]] Cacciapuoti F.Molecular mechanisms of left ventricular hypertrophy (LVH) in systemic hypertension (SH)-possible therapeutic perspectives. J Am Soc Hypertens 2011;5(6):449-455.

[[99]] Huo ZJ, Li Q, Tian GH, et al.The ameliorating effects of longterm electroacupuncture on cardiovascular remodeling in spontaneously hypertensive rats. BMC Complement Altern Med 2014;14:118.

[[100]] Lan D, Xu N, Sun J, et al.Electroacupuncture mitigates endothelial dysfunction via effects on the PI3K/Akt signalling pathway in high fat diet-induced insulin-resistant rats. Acupunct Med 2018;36(3):162-169.

[[101]] Bhat AK, Krishna KV, Johnson JD.An integrative approach with Ayurveda and Traditional Chinese Acupuncture in post covid parosmia - A case study. J Ayurveda Integr Med 2023;14(1):100560.

[[102]] Yin X, Cai SB, Chen LM, et al.17 cases of severe COVID-19 treated with acupuncture and medicine. Zhongguo Zhen Jiu 2021;41(05):498-500.

[[103]] Yin X, Cai SB, Tao LT, et al.Recovery of a patient with severe COVID-19 by acupuncture and Chinese herbal medicine adjuvant to standard care. J Integr Med 2021;19(5):460-466.

[[104]] Tao LT, Huang TL, Zheng DW, et al.Case of professor Xu ZOU's acupuncture technique for “benefiting kidney and strengthening anti-pathogenic qi” in promoting the absorption of COVID-19. World J Acupunct Moxibustion 2020;30(3):167-170.

[[105]] Luo ZH, Wang KX, Zhang YL, et al.Clinical observation on filiform-fire needling of “Biaoben acupoint combination” for 33 cases of sequelae of coronavirus disease 2019 during recovery period. Zhongguo Zhen Jiu 2022;42(7):760-764.

[[106]] Li ZJ, Cai QX, Yuan J, etc. Clinical study on Xueshuantong point injection for novel coronavirus pneumonia. Shanghai J Acupunct Moxibust 2021,40(10):1182-1184.

[[107]] Wang H, Dai C, Xiao L, et al.Clinical efficacy and safety of intracutaneous acupuncture combined with western medicine in the treatment of 3 cases of severe COVID-19. Chin J Hospital Infect 2021;31(24):3699-3702.

[[108]] Cheng SI.Medical acupuncture as a treatment for novel COVID- 19-related respiratory distress: personal experience from a frontline anesthesiologist. Med Acupunct 2021;33(1):83-85.

[[109]] Wang YZ, Li B, Wang LP, et al.Acupuncture as adjuvant therapy for 32 cases of coronavirus disease 2019. Zhongguo Zhen Jiu 2022;42(6):634-638.

[[110]] Jania C.The treatment of long COVID with Chinese medicine: a case report. J Chin Med 2021;2021(127):17-22.

[[111]] Gong YB, Shi XJ, Zhang Y, etc. Clinical application and practice of acupuncture therapy in novel coronavirus pneumonia. Zhongguo Zhen Jiu 2021;41(2):142-144.

[[112]] Gong YB, Shi XJ, Zhang Y, et al.Practice and experience in treating novel coronavirus pneumonia with tube acupuncture in negative pressure ward. Shanghai J Acupuncture Moxibustion 2021;40(4):487-490.

[[113]] Luo ZH, Wang KX, Zhang YL, et al.Thumb-tack needles based on “Biaoben acupoint compatibility” for sequela of COVID-19 during recovery period. Zhongguo Zhen Jiu 2022;42(3):281-286.

[[114]] Luo YH, Luo YF, Hu SF.Observation on ear point pressing beans combined with Yijinjing to improve stress disorder in mild COVID-19 patients . Pract Clin Med 2021;22(1):57-59.

[[115]] Yang C, Ma Y, Mei JH, et al.Observation of therapeutic effect on coronavirus disease 2019 with insomnia in treatment with baduanjin and auricular point sticking therapy. Zhongguo Zhen Jiu 2021;41(3):243-246.

[[116]] Gong YB, Yang ZL, Liu Y, et al.Two cases of corona virus disease 2019 (COVID-19) treated with the combination of acupuncture and medication in bedridden patients2. World J Acupunct Moxibustion 2020;30(3):171-174.

[[117]] Trager RJ, Brewka EC, Kaiser CM, et al.Acupuncture in multidisciplinary treatment for post-COVID-19 syndrome. Med. Acupunct 2022;34(3):177-183.

RIGHTS & PERMISSIONS

2023 Acupuncture and Herbal Medicine